tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Pharma Foods Reports Special Loss Due to Subsidiary Impairment

Story Highlights
Pharma Foods Reports Special Loss Due to Subsidiary Impairment

Meet Your ETF AI Analyst

An update from Pharma Foods International Co., Ltd. ( (JP:2929) ) is now available.

Pharma Foods International Co., Ltd. reported a special loss of ¥2.3 billion in its non-consolidated financial statements due to an impairment of shares in its subsidiary, Meiji Yakuhin Co., Ltd. Despite strong sales and increased mail-order customers for Meiji Yakuhin, the upfront advertising investments could not be recovered within a single fiscal year, leading to a decline in net assets. However, this loss does not affect the company’s consolidated financial results.

The most recent analyst rating on (JP:2929) stock is a Hold with a Yen916.00 price target. To see the full list of analyst forecasts on Pharma Foods International Co., Ltd. stock, see the JP:2929 Stock Forecast page.

More about Pharma Foods International Co., Ltd.

Pharma Foods International Co., Ltd. operates in the pharmaceutical industry, focusing on health-related products. The company is involved in the production and sale of products that promote health, such as LACTRON Tablets, which address intestinal health issues.

Average Trading Volume: 161,288

Technical Sentiment Signal: Buy

Current Market Cap: Yen28.07B

See more insights into 2929 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1